“We are extremely excited to have this opportunity,” said Carrie Ward, Senior Vice President of Qlarant. “We have a dedicated team of professionals comprised of investigators, pharmacists, nurses, and data analysts who bring extensive experience and subject matter expertise to the work at hand. We are ready and prepared to do this important work.”

Under CMS direction, Qlarant will perform various functions related to potential fraud, waste and abuse from prescribers, pharmacies, and beneficiaries. The primary focus will be on complaint intake and response, data analysis, assessing leads, investigative action, administrative actions and program integrity. The program is required to work in compliance with all federal and state laws, regulations, and CMS requirements.

Qlarant, headquartered in Easton, Maryland, is a national leader in battling FWA and has offices and home-based associates across the country. “We look forward to the opportunity to continue working to ensure Medicare and Medicaid funds are properly protected,” commented Sandy Love, President, Qlarant Integrity Solutions.

About QlarantQlarant is a not-for-profit nationally respected leader in fighting fraud, waste & abuse, improving program quality, and optimizing performance. The company uses subject matter experts and innovative data sciences and technology to help organizations see risks, solve problems, and seize opportunities. Qlarant provides customized solutions for health and human services organizations, government agencies, and financial and insurance companies. The Qlarant Foundation is the mission arm of the organization and provides grants to services provided in underserved communities. Qlarant employs nearly 500 people and has a 45-year record of accomplishment improving the performance of some of the Nation’s most important programs. www.Qlarant.com